Concepedia

Ralph Tiedt

RT

36

Publications

7.8K

Citations

27

H-Index

2001

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

University Hospital of Basel

Novartis (China)

Novartis (United States)

Ralph Tiedt is an author at Novartis (Switzerland) specializing in medicine, cell biology, and pharmacology.

ORCID

Top concepts

Publications per year

2001–2025

36

Publications

36

A Gain-of-Function Mutation of <i>JAK2</i> in Myeloproliferative Disorders

Róbert Královics, Francesco Passamonti, Andreas Buser et al. · New England Journal of Medicine · 2005 · 3.4K citations · Full text

Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening

E. Robert McDonald, Antoine de Weck, Michael R. Schlabach et al. · Cell · 2017 · 687 citations · Full text

, , +13

Polyclonal Secondary <i>FGFR2</i> Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma

Lipika Goyal, Supriya K. Saha, Leah Y. Liu et al. · Cancer Discovery · 2016 · 527 citations · Full text

Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice

Ralph Tiedt, Hui Hao-Shen, Marta Sobas et al. · Blood · 2007 · 430 citations · Full text

Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo

Ralph Tiedt, Tibor Schomber, Hui Hao-Shen et al. · Blood · 2006 · 409 citations

Rows per page

1–5 of 36